Tscan Therapeutics Inc (NASDAQ: TCRX) – Not A Clear Buying Opportunity?
Tscan Therapeutics Inc (TCRX) concluded trading on Thursday at a closing price of $3.11, with 3.42 million shares of worth about $10.64 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -50.16% during that period and on December 26, 2024 the price saw a […]
